Being so sensitive, the ferritin–ESR ratio identified severe COVID-19 patients regardless of DOCK8 or fHLH mutation (Table 4), likely reflecting other risk factors for severe disease in those without known CSS gene mutations. This evidence concerns the gene DOCK8 and COVID-19.